✦ LIBER ✦
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis–associated active interstitial lung disease
✍ Scribed by Dinesh Khanna; Rajeev Saggar; Maureen D. Mayes; Fereidoun Abtin; Philip J. Clements; Paul Maranian; Shervin Assassi; Rajan Saggar; Ram R. Singh; Daniel E. Furst
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 89 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.